相关实验视频
Updated: Jun 23, 2025

09:45
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
9.4K
SUMOylation的向导致cBAF复杂的稳定和破坏SS18::SSX转录组在Synovial Sarcoma中的转录组
Konstantinos V Floros1,2, Carter K Fairchild1,3, Jinxiu Li4
1VCU Philips Institute, Virginia Commonwealth University School of Dentistry and Massey Comprehensive Cancer Center, Richmond VA, 23298 USA.
Research square
|June 17, 2024
概括
突肉瘤是由SS18::SSX驱动的,它破坏了染色质重塑. 用TAK-981向SUMOylation通路恢复正常的复合体,抑制瘤生长,并提高化疗的疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 染色体生物学 染色体生物学
背景情况:
- 突肉瘤 (SS) 是由SS18::SSX融合蛋白驱动的.
- SS18:SSX破坏了依赖ATP的染色质重塑BAF (SWI/SNF) 复合体,促进了瘤发生.
研究的目的:
- 调查针对SS.中的SUMOylation途径的治疗潜力.
- 为了阐明SAE1/2抑制剂TAK-981在SS中的作用机制.
主要方法:
- 使用小分子抑制剂TAK-981向SAE1/2 SUMOylation.使用小分子抑制剂TAK-981向SAE1/2 SUMOylation.
- 分析了染色质重塑复杂的组成和转录变化.
- 在SS模型中评估了瘤抑制和与化疗的协同效应.
主要成果:
- SS对TAK-981敏感,TAK-981去SUMOylatesSMARCE1,恢复了正规的BAF (cBAF) 复合体.
- TAK-981将转录从SS18::SSX-ncBAF程序转移,从而诱导DNA损伤和细胞死亡.
- 在人类和小鼠的SS模型中,TAK-981证明了瘤抑制,并与瘤回归的化疗协同作用.
结论:
- 准SUMOylation路径代表了SS的治疗脆弱性.
- TAK-981可以恢复cBAF复合体并阻止瘤转录,为SS.提供潜在的治疗策略.
- TAK-981定位用于治疗SS的临床使用,特别是与化疗结合使用.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
RNA Splicing
56.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
Cytoskeletal Accessory Proteins
3.0K
The cytoskeleton is an essential cell component that plays several structural and functional roles. However, the filaments that make up the cytoskeleton cannot function independently and depend on the accessory or ancillary proteins to effectively carry out their function. Accessory proteins associate with cytoskeletal filaments and their monomers, aiding filament formation and function. They also help in the cross-communication among cytoskeletal filaments. Cytoskeletal accessory proteins are...
3.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

